Based on Phase 2 safety data (Jastreboff et al., NEJM 2023), common early adverse effects reported include: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea or constipation Reduced appetite Mild fatigue or dizziness These effects are consistent with the GLP-1 receptor agonist class and typically reflect the gut's adaptation to altered gastric emptying and hormonal signalling
We observed, that patients who developed PHLF displayed 2.3-fold higher GLP-1 plasma concentrations preoperatively, compared to patients without PHLF ( p = 0.030)
Because they simply dont feel as rewarding, because the true signal of nutrient density is winning over taste and sugar rewards
Agago DE, Hanif N, Ajay Kumar AS, et al
Demographic, clinical, and surgical data, including age, gender, pre-surgical BMI, type of surgery performed, baseline and nadir weight, comorbidities at baseline and during follow-up, as well as details of arGLP-1 (duration and dosing), were obtained
Suggested Use / Directions: Take 2 capsules daily, or as directed by your healthcare practitioner